Clear Search sequence regions


  • Akt (1)
  • Akt 1 (3)
  • chronic bronchitis (1)
  • cytokines (4)
  • edema (2)
  • EGFR (6)
  • egfr protein human (1)
  • humans (1)
  • lung (15)
  • lung edema (1)
  • man (9)
  • mice (3)
  • protein human (1)
  • receptors (2)
  • rt pcr (1)
  • veronica (2)
  • ZO 1 (4)
  • Sizes of these terms reflect their relevance to your search.

    The dried aerial parts of Veronica linariifolia subsp. dilatata (Nakai & Kitag.) D.Y.Hong named Shui Man Jing (SMJ) is a traditional Chinese medicine with a long history of clinical use in the treatment of chronic bronchitis and coughing up blood, however, its role on acute lung injury (ALI) has not been revealed yet. To assess the efficiency of SMJ on ALI and to investigate whether it inhibited endothelial barrier dysfunction by regulating the EGFR/Akt/ZO-1 pathway to alleviate ALI in vivo and in vitro based on the result of network pharmacology. An in vivo model of ALI was established using inhalation of atomized lipopolysaccharide (LPS), and the effects of SMJ on ALI were evaluated through histopathological examination and inflammatory cytokines, lung histology and edema, vascular and alveolar barrier disruption. Network pharmacology was applied to predict the mechanism of SMJ in the treatment of ALI. The crucial targets were validated by RT-PCR, Western Blotting, molecular docking, immunohistochemistry and immunofluorescence methods in vivo and in virto. Administration of SMJ protected mice against LPS-induced ALI, including ameliorating the histological alterations in the lung tissues, and decreasing lung edema, protein content of bronchoalveolar lavage fluid, infiltration of inflammatory cell and secretion of cytokines. SMJ exerted protective effects in ALI by inhibiting endothelial barrier dysfunction in mice and bEnd.3 cell. SMJ relieved endothelial barrier dysfunction induced by LPS through upregulating the EGFR expression. SMJ also increased the phosphorylation of Akt, and ZO-1 expression both in vivo and in vitro. SMJ attenuates vascular endothelial barrier dysfunction for LPS-induced ALI via EGFR/Akt/ZO-1 pathway, and is a promising novel therapeutic candidate for ALI. Copyright © 2023 Elsevier B.V. All rights reserved.

    Citation

    Huayan Wu, Longlong Wu, Wenchao Yu, Chenming Gu, Yiming Li, Kaixian Chen, Liuqiang Zhang, Fei Qian. Veronica linariifolia subsp. dilatata ameliorates LPS-induced acute lung injury by attenuating endothelial cell barrier dysfunction via EGFR/Akt/ZO-1 pathway. Journal of ethnopharmacology. 2024 Mar 01;321:117545

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38056533

    View Full Text